Eric B Suhler - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Eric B Suhler

Showing results (131-140 of 134) with videos related to

Pageof 14

Sort By:

You have reached the last page of results.This site can display upto 134 results.

Ophthalmology|November 6, 2020

Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisEric B Suhler, Glenn J Jaffe, Eric Fortin, et al.

Ocular Immunology and Inflammation|April 15, 2025

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious UveitisSapna S Gangaputra, Craig W Newcomb, Gui-Shuang Ying, et al.

BMJ Oncology|January 31, 2025

Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.

Ophthalmology|July 27, 2023

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.

Pageof 14

Search research articles

Showing results (131-140 of 134) with videos related to

Sort By:

Pageof 14

You have reached the last page of results.This site can display upto 134 results.

Ophthalmology|November 6, 2020

Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or PanuveitisEric B Suhler, Glenn J Jaffe, Eric Fortin, et al.

Ocular Immunology and Inflammation|April 15, 2025

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious UveitisSapna S Gangaputra, Craig W Newcomb, Gui-Shuang Ying, et al.

BMJ Oncology|January 31, 2025

Use of immunosuppression and subsequent cancer incidence: cohort studyJeanine M Buchanich, Craig W Newcomb, Terri L Washington, et al.

Ophthalmology|July 27, 2023

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer MortalityJohn H Kempen, Craig W Newcomb, Terri L Washington, et al.

Pageof 14